Delivery Order SPE2DB20D9331-SPE2DB25FL0Q9
Award Date
1/31/25
Potential Completion Date
2/24/25
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,424.46, is for the delivery of Xolair 300 mg/2 ml autoinjector vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Xolair 300 mg/2 ml autoinjector. The contract, valued at $3,424.46, has an ultimate completion date of February 3, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $34,244.60, is for the delivery of the pharmaceutical product Xolair 300 mg/2 ml autoinjector. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $34,244.60, is for the provision of Xolair 300 mg/2 ml autoinjector to the DLA for distribution to various U.S. Department of Defense (DoD) healthcare facilities worldwide. The contract has an ultimate completion date of August 19, 2024. This award is part of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Xolair 300 mg/2 ml autoinjectors, valued at $6,848.92. The contract is a firm fixed-price delivery order with a completion date of December 18, 2024. DMS Pharmaceutical Group Inc. has an Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,848.92 contract is for the supply of Xolair 300 mg/2 ml autoinjector, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,273.38 contract is for the delivery of Xolair 300 mg/2 ml autoinjector medication to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $15,245.24 contract is for the supply of 4566873659 ! XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product, with a period of performance through January 29, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,712.23 award is for the supply of Xolair 300 mg/2 ml autoinjector medication, with an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,848.92 contract is for the delivery of 4,566,869,571 units of Xolair 300 mg/2 ml autoinjector. This delivery order is part of a larger, single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which enables the DLA to place orders for a...